Jump to content

Talk:Transcriptomics technologies/GA1

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Stigmatella aurantiaca (talk | contribs) at 19:51, 29 August 2017 (GA Review: more precise). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

GA Review

GA toolbox
Reviewing

Article (edit | visual edit | history) · Article talk (edit | history) · Watch

Reviewer: Stigmatella aurantiaca (talk · contribs) 10:49, 24 August 2017 (UTC)[reply]


I will begin the review on the weekend. Stigmatella aurantiaca (talk) 10:49, 24 August 2017 (UTC)[reply]

Rate Attribute Review Comment
1. Well-written:
1a. the prose is clear, concise, and understandable to an appropriately broad audience; spelling and grammar are correct. I anticipate that most of my forthcoming detailed comments will concern this topic. There is a significant amount of jargon that, although familiar to workers in the field, may require the addition of explanatory footnotes before this article will be suitable reading for, say, college sophomore/junior students in life sciences who have finished a year long course in cell biology, a semester course in biotechnology, but not much else. For the purposes of this review, I'm brushing up with Alberts, Molecular Biology of the Cell, 6th edition (2014) and Clark, Biotechnology, Second Edition (2015).
1b. it complies with the Manual of Style guidelines for lead sections, layout, words to watch, fiction, and list incorporation.
2. Verifiable with no original research:
2a. it contains a list of all references (sources of information), presented in accordance with the layout style guideline.
2b. reliable sources are cited inline. All content that could reasonably be challenged, except for plot summaries and that which summarizes cited content elsewhere in the article, must be cited no later than the end of the paragraph (or line if the content is not in prose).
2c. it contains no original research. Although principal editor is involved in this work, he has done an excellent job placing his own contributions in proper perspective. I have no issues with possible COI.
2d. it contains no copyright violations or plagiarism. Large parts are derived from Lowe R, ShirleyN, Bleackley M, Dolan S, Shafee T (2017) Transcriptomics technologies. PLoS Comput Biol 13(5) e1005457 which is published under Creative Commons Attribution License. Likewise also matches against abstract on PubMed.
3. Broad in its coverage:
3a. it addresses the main aspects of the topic. This article focuses on transcriptomics technologies rather than on transcriptomics. The articles on Transcriptome and Expressomics provide rather inadequate introduction to concepts that this article takes for granted. No fault of this article, of course.
3b. it stays focused on the topic without going into unnecessary detail (see summary style).
4. Neutral: it represents viewpoints fairly and without editorial bias, giving due weight to each.
5. Stable: it does not change significantly from day to day because of an ongoing edit war or content dispute.
6. Illustrated, if possible, by media such as images, video, or audio:
6a. media are tagged with their copyright statuses, and valid non-free use rationales are provided for non-free content.
6b. media are relevant to the topic, and have suitable captions.
7. Overall assessment.